Butaxamine

Butaxamine (INN, also known as butoxamine) is a β₂-selective beta blocker.[1][2] Its primary use is in experimental situations in which blockade of β₂ receptors is necessary to determine the activity of the drug (i.e. if the β₂ receptor is completely blocked, but the given effect is still present, the given effect is not a characteristic of the β₂ receptor). It has no clinical use. An alternative name is α-(1-[tert-butylamino]ethyl)-2,5-dimethoxybenzyl alcohol.

Butaxamine

Clinical data
ATC code	None
Identifiers
IUPAC name (1S,2S)-1-(2,5-dimethoxyphenyl)-2- (tert-butylamino)propan-1-ol
CAS Number	2922-20-5^Y
PubChem CID	21909
ChemSpider	20593^Y
UNII	0NM31M53PW
ChEMBL	ChEMBL289093
CompTox Dashboard (EPA)	DTXSID60897115 DTXSID70896997, DTXSID60897115
Chemical and physical data
Formula	C15H25NO3
Molar mass	267.369 g·mol^−1
3D model (JSmol)	Interactive image
SMILES Cl.O(c1ccc(OC)cc1C(O)C(NC(C)(C)C)C)C
InChI InChI=1S/C15H25NO3.ClH/c1-10(16-15(2,3)4)14(17)12-9-11(18-5)7-8-13(12)19-6;/h7-10,14,16-17H,1-6H3;1H^Y Key:URPAECSKKQLCII-UHFFFAOYSA-N^Y
(verify)

See also

• Bupropion
• Methoxamine

References

1. "Definition: butoxamine from Online Medical Dictionary".
2. Hillman KL, Doze VA, Porter JE (August 2005). "Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus". J. Pharmacol. Exp. Ther. 314 (2): 561–7. doi:10.1124/jpet.105.084947. PMID 15908513.